Company intelligence / Profile preview

Abbiotec

Escondido, California, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Abbiotec develops and commercializes next-generation antibodies, peptides, and related reagents for research use. Their products support cell biology, immunology, cancer, hematology, and neurodegenerative disease research. There are no clinical therapeutic programs or clinical results; the company is not a therapeutic developer but rather a supplier of reagents to facilitate discovery and assay development in academic and biopharma settings.

Therapeutic areas: PsychiatryInfectious DiseasesHematologyOncologyNeurology
Modalities: AntibodyMonoclonal antibodyPolyclonal antibodyPeptidesProtein
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Abbiotec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abbiotec.

Explore the full profile